Discover 1,973 paid clinical trials in Fort Lauderdale, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,973
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma,
Location: Miami FL, Houston TX, Lake Success NY, Dallas TX,
Sponsor: PanTher Therapeutics
Sex: All
Age: 18+
Code: NCT06673017
Phase1, Recruiting
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
for
Gastrointestinal Stromal Tumor (GIST)
Location: Miami FL, Jacksonville FL, Nashville TN, New York NY,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06630234
Phase1, Phase2, Recruiting
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
for
Neoplasms, Arteriovenous Malformation of Central Nervous System,
Location: Miami FL, Detroit MI
Sponsor: The Radiosurgery Society
Sex: All
Age: 0+
Code: NCT01885299
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
for
Myelodysplastic Syndromes, Cytopenia
Location: Miami FL, Tampa FL, Memphis TN, Bethesda MD,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT04419649
Phase2, Recruiting
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: Cooper City FL, Miami FL, West Columbia SC,
Sponsor: Origin Inc.
Sex: All
Age: 22 - 70+
Code: NCT03078933
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Miami FL, Jacksonville FL, Atlanta GA, Durham NC,
Location: Miami FL, Denver CO, Nashville TN, Fairfax VA,
Sponsor: Nuvalent Inc.
Sex: All
Age: 18+
Code: NCT06521554
Phase1, Recruiting
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
for
Chronic Myelomonocytic Leukemia
Location: Miami FL, Houston TX, Indianapolis IN
Sponsor: Huda Salman
Sex: All
Age: 18+
Code: NCT06071624
Phase1, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
for
Post Operative Surgical Site Infection
Location: West Palm Beach FL, Atlanta GA, Charlotte NC,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 64
Code: NCT04678154
Phase3, Recruiting
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
for
Acute Monocytic Leukemia, Acute Myeloid Leukemia
Location: Miami FL, Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06504459
Phase2, Recruiting
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
for
Psoriatic Arthritis
Location: Loxahatchee Groves FL, Riverview FL, Plant City FL,
Sponsor: University of Pennsylvania
Sex: All
Age: 18 - 70+
Code: NCT05669833
Phase3, Recruiting
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
for
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia
Location: Miami FL, Houston TX, Canton OH, New Hyde Park NY,
Sponsor: Hoth Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05639933
Phase2, Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for
Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer,
Location: Miami FL, Port Saint Lucie FL, Orlando FL,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT05983432
Phase1, Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)